CAS
GILD icon

Coppell Advisory Solutions’s Gilead Sciences GILD Stock Holding History

Coppell Advisory Solutions’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Buy
+11,705
New +$1.54M 0.02% 428
2026
Q1 		– Sell
-19,475
Closed -$2.4M – 161
2025
Q4 		$2.4M Sell
19,475
-568
-3% -$69K 0.24% 88
2025
Q3 		$2.26M Sell
20,043
-101
-0.5% -$11.5K 0.24% 89
2025
Q2 		$2.23M Sell
20,144
-3,179
-14% -$338K 0.26% 73
2025
Q1 		$2.43M Sell
23,323
-11,719
-33% -$1.21M 0.34% 62
2024
Q4 		$3.22M Sell
35,042
-2,556
-7% -$230K 0.45% 40
2024
Q3 		$3.14M Sell
37,598
-373
-1% -$28.5K 0.46% 38
2024
Q2 		$2.61M Buy
+37,971
New +$2.53M 0.43% 48
2023
Q4 		$2.2M Buy
27,142
+9,049
+50% +$704K 0.44% 50
2023
Q3 		$1.55M Sell
18,093
-4,218
-19% -$324K 0.53% 48
2023
Q2 		$1.7M Buy
22,311
+3,177
+17% +$253K 0.48% 46
2023
Q1 		$1.56M Buy
19,134
+1,041
+6% +$86.2K 0.51% 46
2022
Q4 		$1.55M Buy
+18,093
New +$1.43M 0.53% 48
2020
Q4 		$548K Buy
+9,402
New +$567K 0.28% 95

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Coppell Advisory Solutions's GILD Position: Q2 2026 in Review

Coppell Advisory Solutions opened a new position in Gilead Sciences (GILD) in Q2 2026: 11,705 shares worth $210K. The stake represents 0.02% of the portfolio and ranks #428 among its holdings. This is a return to the name: Coppell Advisory Solutions previously reported a position in GILD as recently as Q4 2025.

Coppell Advisory Solutions first reported a position in GILD in Q4 2020 and has held it in 14 quarters since. The position peaked at $3.22M in Q4 2024. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Coppell Advisory Solutions held 11,705 shares of Gilead Sciences worth $210K as of Q2 2026.
  • Gilead Sciences was a new Coppell Advisory Solutions position in Q2 2026.
  • Gilead Sciences made up 0.02% of Coppell Advisory Solutions's portfolio in Q2 2026, its #428 holding.
  • Coppell Advisory Solutions first reported a position in Gilead Sciences in Q4 2020 and has held it in 14 quarters since.
  • Coppell Advisory Solutions's Gilead Sciences position peaked at $3.22M in Q4 2024.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Coppell Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.